AI assistant
Sending…
Entera Bio Ltd. — Director's Dealing 2024
Nov 20, 2024
35604_dirs_2024-11-20_dd662cfd-af17-432d-a435-b7ccf7ed0081.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Entera Bio Ltd. (ENTX)
CIK: 0001638097
Period of Report: 2024-11-14
Reporting Person: Knoll Capital Management, LLC (10% Owner)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Ordinary Shares, par value NIS 0.0000769 per share | 5534275 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Pre-funded warrant | $0.0 | 2028-12-22 | Ordinary Shares, par value NIS 0.0000769 per share (347604) | Direct | |
| Warrants (right to buy) | $1 | 2028-12-22 | Ordinary Shares, par value NIS 0.0000769 per share (1197604) | Direct |
More from Entera Bio Ltd.
Regulatory Filings
2026
May 15
Interim / Quarterly Report
2026
May 8
Regulatory Filings
2026
Mar 25
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 11
Director's Dealing
2026
Feb 9